Table 1 The HBV-related cohorts in CCI-HBV areas
| CCI area of diseases | Group | Cohort | Target capacity by 2020 | Present capacity (2015) |
|---|---|---|---|---|
| HBV | Uninfected | HBV new infection rates in the general population cohort | > 1,000,000 | 1,360,000 |
| Adult HBV vaccination intervention cohort | > 500,000 | 639,799 | ||
| Infected | HBV carrier cohort | > 50,000 | 70,890 | |
| Chronic HBV antiviral treatment cohort | > 30,000 | 34,083 | ||
| Hepatic cirrhosis antiviral treatment cohort | > 2000 | 2257 |